UnknownEarly Phase 1NCT04596462
Characterizing SAPHO With 68Ga-FAPI PET/CT
Studying SAPHO syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Peking Union Medical College Hospital
- Principal Investigator
- Hongli Jing, MDPeking Union Medical College Hospital
- Intervention
- 68Ga-FAPI(drug)
- Enrollment
- 70 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2020 – 2021
Study locations (1)
- Peking union medical college hospital, Beijing, Dongcheng, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04596462 on ClinicalTrials.govOther trials for SAPHO syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07081880Study of the Pathophysiological Mechanisms Involved in the SAPHO Syndrome: Genetic Component and Immune ResponseFondation Hôpital Saint-Joseph
- RECRUITINGPHASE2, PHASE3NCT06011889Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO SyndromeNational Institute of Geriatrics, Rheumatology and Rehabilitation, Poland
- RECRUITINGNCT07086599Typological Study of Sleep Pathologies During Psoriatic Rheumatism and SAPHO Syndrome: Prospective Study Within the Paris Saint-Joseph Hospital Group"Fondation Hôpital Saint-Joseph